ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 195,97
0,35%
Dow Jones
39 806,77
-0,49%
DAX
18 768,96
0,33%
Brent Oil
83,53
-0,08%
Bitcoin
69 616,38
5,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Arbutus Biopharma Corporation (ABUS)

  7. Arbutus Biopharma Corporation (ABUS) Actualités

ABUS

Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ABUS
DateHeureSourceTitreSymboleSociété
17/05/202415h03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
17/05/202415h00Business WireWhitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize ValueNASDAQ:ABUSArbutus Biopharma Corporation
09/05/202414h00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ABUSArbutus Biopharma Corporation
07/05/202413h30GlobeNewswire Inc.Arbutus to Participate in Two Upcoming Investor ConferencesNASDAQ:ABUSArbutus Biopharma Corporation
02/05/202413h30GlobeNewswire Inc.Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
02/05/202413h25GlobeNewswire Inc.Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024NASDAQ:ABUSArbutus Biopharma Corporation
18/04/202413h30GlobeNewswire Inc.Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
04/04/202414h30GlobeNewswire Inc.Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against ModernaNASDAQ:ABUSArbutus Biopharma Corporation
05/03/202422h48Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABUSArbutus Biopharma Corporation
29/02/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABUSArbutus Biopharma Corporation
29/02/202413h30GlobeNewswire Inc.Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
15/02/202413h30GlobeNewswire Inc.Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
14/02/202422h38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABUSArbutus Biopharma Corporation
06/02/202401h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
08/01/202413h30GlobeNewswire Inc.Arbutus Announces 2024 Corporate Objectives and Provides Financial UpdateNASDAQ:ABUSArbutus Biopharma Corporation
21/11/202314h00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABUSArbutus Biopharma Corporation
08/11/202313h30GlobeNewswire Inc.Arbutus to Present at Jefferies London Healthcare ConferenceNASDAQ:ABUSArbutus Biopharma Corporation
07/11/202322h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABUSArbutus Biopharma Corporation
07/11/202313h30GlobeNewswire Inc.Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
07/11/202313h15GlobeNewswire Inc.Arbutus Announces CEO, William Collier, to Retire December 31, 2023NASDAQ:ABUSArbutus Biopharma Corporation
24/10/202313h30GlobeNewswire Inc.Arbutus to Report Third Quarter 2023 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
18/10/202313h30GlobeNewswire Inc.Arbutus to Present at H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Virtual ConferenceNASDAQ:ABUSArbutus Biopharma Corporation
11/10/202314h05GlobeNewswire Inc.Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023NASDAQ:ABUSArbutus Biopharma Corporation
11/09/202322h15GlobeNewswire Inc.Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway ExtendedNASDAQ:ABUSArbutus Biopharma Corporation
03/08/202322h18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABUSArbutus Biopharma Corporation
03/08/202313h30GlobeNewswire Inc.Arbutus Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
20/07/202313h30GlobeNewswire Inc.Arbutus to Report Second Quarter 2023 Financial Results and Provide Corporate UpdateNASDAQ:ABUSArbutus Biopharma Corporation
13/07/202322h11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABUSArbutus Biopharma Corporation
12/07/202313h30GlobeNewswire Inc.Arbutus Appoints Melissa V. Rewolinski, PhD to its Board of DirectorsNASDAQ:ABUSArbutus Biopharma Corporation
10/07/202322h01GlobeNewswire Inc.Arbutus Appoints Two New ExecutivesNASDAQ:ABUSArbutus Biopharma Corporation
 Showing the most relevant articles for your search:NASDAQ:ABUS

Dernières Valeurs Consultées

BIT
P21381
NLBNPIT21381 20240517 32...
TG
A180ME
Wells Fargo
TSXV
ODD
Odd Burger
TG
A2RYQC
Aktia Bank
BOV
MTSA4F
METISA PN
UNSW3
DPIUSDT
DefiPulse Index
NASDAQ
TMPOW
Tempo Automation
BIT
P1UI57
NLBNPIT1UI57 20991231 45...
EU
BEC0000BIGW1
Crelan Bank Frn until 27...
BIT
P1XFZ9
NLBNPIT1XFZ9 20991231 88...
BIT
I09866
IT0005574923 20240603 7.5
USOTC
DJSCF
Ishares (PK)
USOTC
ECNLF
Aquafil (QX)
BIT
P1Y0X5
NLBNPIT1Y0X5 20991231 18...
COIN
RPMUSD
TG
A3LTF7
ALD
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés